Related references
Note: Only part of the references are listed.Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Artur Nowinski et al.
NUTRITION (2018)
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction
Katharina Schuett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
High mass accuracy assay for trimethylamine N-oxide using stable-isotope dilution with liquid chromatography coupled to orthogonal acceleration time of flight mass spectrometry with multiple reaction monitoring
Liam M. Heaney et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Pathophysiology and clinical evaluation of acute heart failure
Robert J. Mentz et al.
NATURE REVIEWS CARDIOLOGY (2016)
Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012
Tonje Thorvaldsen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Trimethylamine N-oxide and prognosis in acute heart failure
Toru Suzuki et al.
HEART (2016)
Pathogenic Gut Flora in Patients With Chronic Heart Failure
Evasio Pasini et al.
JACC-HEART FAILURE (2016)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure
W. H. Wilson Tang et al.
JOURNAL OF CARDIAC FAILURE (2015)
Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide
Kymberleigh A. Romano et al.
MBIO (2015)
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
M. Troseid et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2015)
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
Richard W. Troughton et al.
EUROPEAN HEART JOURNAL (2014)
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
Serge Masson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Altered intestinal function in patients with chronic heart failure
Anja Sandek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Share Paper
